XBiotech Breakthrough, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
XBiotech Inc. (XBIT)
Last xbiotech inc. earnings: 8/9 03:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
xbiotech.com/about/investors.html
Company Research
Source: Seeking Alpha
SummaryXBiotech makes a crucial breakthrough in True Human antibodies development.Novocure begins pivotal Phase 2 trial for brain cancer therapy.Genfit discontinues Phase 3 RESOLVE-IT NASH study.XBiotech makes a crucial breakthrough in True Human antibodies DevelopmentXBiotech Inc.(NASDAQ:XBITXBiotech had sold its earlier-generation antibody in 2019 for $750 million in cash and up to $600 million in milestone payments. The company is working on a replacement for that antibody panel. Sushma Shivaswamy, the company's chief scientific officer, said, "We believe that the new molecule has the potential to be another blockbuster therapeutic with proven industry appeal. Having a production platform is a significant step toward realizing this goal."Pursuant to the sale of its previous generation antibody panel, XBiotech had retained the right to develop new True Human anti-IL-1? antibodies for use in all segments of medicine except dermatology. The company has now engineered a cell-based prod
Show less
Read more
Impact Snapshot
Event Time:
XBIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XBIT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XBIT alerts
High impacting XBiotech Inc. news events
Weekly update
A roundup of the hottest topics
XBIT
Sec Filings
- 5/1/24 - Form ARS
- 5/1/24 - Form DEFA14A
- 5/1/24 - Form DEF
- XBIT's page on the SEC website